Abbott (NYSE:ABT) announced that it entered into a strategic partnership with WeightWatchers to help people living with diabetes.
The companies will work together to integrate WeightWatchers’ diabetes-tailored weight management program with Abbott’s FreeStyle Libre continuous glucose monitoring (CGM) products to help them better understand and manage their diabetes and weight.
Get the full story at our sister site, Drug Delivery Business News.